Analytical Sciences Group, King's College, London, UK.
APMIS. 2014 May;122(5):363-8. doi: 10.1111/apm.12154. Epub 2013 Aug 29.
Genetic, molecular and biological studies indicate that rheumatoid arthritis (RA), a severe arthritic disorder affecting approximately 1% of the population in developed countries, is caused by an upper urinary tract infection by the microbe, Proteus mirabilis. Elevated levels of specific antibodies against Proteus bacteria have been reported from 16 different countries. The pathogenetic mechanism involves six stages triggered by cross-reactive autoantibodies evoked by Proteus infection. The causative amino acid sequences of Proteus namely, ESRRAL and IRRET, contain arginine doublets which can be acted upon by peptidyl arginine deiminase thereby explaining the early appearance of anti-citrullinated protein antibodies in patients with RA. Consequently, RA patients should be treated early with anti-Proteus antibiotics as well as biological agents to avoid irreversible joint damages.
遗传、分子和生物学研究表明,类风湿关节炎(RA)是一种严重的关节炎疾病,影响了发达国家约 1%的人口,它是由微生物奇异变形杆菌引起的上尿路感染引起的。已有 16 个不同国家报告了针对变形杆菌的特异性抗体水平升高。致病机制涉及由变形杆菌感染引起的交叉反应性自身抗体触发的六个阶段。变形杆菌的致病氨基酸序列,即 ESRRAL 和 IRRET,含有精氨酸二联体,可被肽基精氨酸脱亚氨酶作用,从而解释了 RA 患者抗瓜氨酸化蛋白抗体的早期出现。因此,RA 患者应尽早用抗奇异变形杆菌抗生素和生物制剂进行治疗,以避免不可逆转的关节损伤。